{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:11:21Z","timestamp":1790266281467,"version":"4.1.0"},"reference-count":155,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T00:00:00Z","timestamp":1605398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006595","name":"Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii","doi-asserted-by":"publisher","award":["PN-III-P1-1.2-PCCDI-2017-0341\/PATHDERM"],"award-info":[{"award-number":["PN-III-P1-1.2-PCCDI-2017-0341\/PATHDERM"]}],"id":[{"id":"10.13039\/501100006595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Considered to be highly lethal if not diagnosed in early stages, cutaneous malignant melanoma is among the most aggressive and treatment-resistant human cancers, and its incidence continues to rise, largely due to ultraviolet radiation exposure, which is the main carcinogenic factor. Over the years, researchers have started to unveil the molecular mechanisms by which malignant melanoma can be triggered and sustained, in order to establish specific, reliable biomarkers that could aid the prognosis and diagnosis of this fatal disease, and serve as targets for development of novel efficient therapies. The high mutational burden and heterogeneous nature of melanoma shifted the main focus from the genetic landscape to epigenetic and epitranscriptomic modifications, aiming at elucidating the role of non-coding RNA molecules in the fine tuning of melanoma progression. Here we review the contribution of microRNAs and lncRNAs to melanoma invasion, metastasis and acquired drug resistance, highlighting their potential for clinical applications as biomarkers and therapeutic targets.<\/jats:p>","DOI":"10.3390\/cancers12113378","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T21:48:52Z","timestamp":1605563332000},"page":"3378","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The Non-Coding Landscape of Cutaneous Malignant Melanoma: A Possible Route to Efficient Targeted Therapy"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7185-9945","authenticated-orcid":false,"given":"Andreea D.","family":"Laz\u0103r","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, University of Bucharest, 050095 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7196-1712","authenticated-orcid":false,"given":"Sorina","family":"Dinescu","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, University of Bucharest, 050095 Bucharest, Romania"},{"name":"Research Institute of the University of Bucharest, 050663 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8103-3693","authenticated-orcid":false,"given":"Marieta","family":"Costache","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, University of Bucharest, 050095 Bucharest, Romania"},{"name":"Research Institute of the University of Bucharest, 050663 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,11,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.bbamcr.2016.01.025","article-title":"Roads to melanoma: Key pathways and emerging players in melanoma progression and oncogenic signaling","volume":"1863","author":"Paluncic","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Lazar, A.D., Dinescu, S., and Costache, M. (2020). Deciphering the Molecular Landscape of Cutaneous Squamous Cell Carcinoma for Better Diagnosis and Treatment. J. Clin. Med., 9.","DOI":"10.3390\/jcm9072228"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1755-148X.2011.00834.x","article-title":"Generation of melanocytes from neural crest cells","volume":"24","author":"Sommer","year":"2011","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.0303-6987.2005.00281.x","article-title":"Ultraviolet radiation and skin cancer: Molecular mechanisms","volume":"32","author":"Hussein","year":"2005","journal-title":"J. Cutan Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Blumenberg, M. (2017). Molecular Mechanisms and Biomarkers of Skin Photocarcinogenesis. Human Skin Cancers: Pathways, Mechanisms, Targets and Treatments, IntechOpen.","DOI":"10.5772\/68061"},{"key":"ref_6","unstructured":"Cancer Genome Atlas Network (2015). Genomic Classification of Cutaneous Melanoma. Cell, 161, 1681\u20131696."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0046-8177(84)80310-X","article-title":"A study of tumor progression: The precursor lesions of superficial spreading and nodular melanoma","volume":"15","author":"Clark","year":"1984","journal-title":"Hum. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1038\/onc.2013.194","article-title":"Melanoma metastasis: New concepts and evolving paradigms","volume":"33","author":"Damsky","year":"2014","journal-title":"Oncogene"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/ng0994-15","article-title":"Germline p16 mutations in familial melanoma","volume":"8","author":"Hussussian","year":"1994","journal-title":"Nat. Genet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/jnci\/95.10.723","article-title":"p16\/cyclin-dependent kinase inhibitor 2A deficiency in human melanocyte senescence, apoptosis, and immortalization: Possible implications for melanoma progression","volume":"95","author":"Sviderskaya","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1038\/sj.onc.1206446","article-title":"Human melanocyte senescence and melanoma susceptibility genes","volume":"22","author":"Bennett","year":"2003","journal-title":"Oncogene"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1056\/NEJMra052166","article-title":"Melanoma","volume":"355","author":"Miller","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"656","DOI":"10.18632\/oncotarget.6394","article-title":"Molecular pathway activation features linked with transition from normal skin to primary and metastatic melanomas in human","volume":"7","author":"Shepelin","year":"2016","journal-title":"Oncotarget"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1126\/science.aaf2784","article-title":"Metastasis as an evolutionary process","volume":"352","author":"Turajlic","year":"2016","journal-title":"Science"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","article-title":"Emerging biological principles of metastasis","volume":"168","author":"Lambert","year":"2017","journal-title":"Cell"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nature12628","article-title":"Selection and adaptation during metastatic cancer progression","volume":"501","author":"Klein","year":"2013","journal-title":"Nature"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/ijc.24916","article-title":"Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis","volume":"126","author":"Stoecklein","year":"2010","journal-title":"Int. J. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1172\/JCI42002","article-title":"Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma","volume":"120","author":"Eyles","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nrc2627","article-title":"Parallel progression of primary tumours and metastases","volume":"9","author":"Klein","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1158\/2159-8290.CD-15-0369","article-title":"Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets","volume":"5","author":"Brastianos","year":"2015","journal-title":"Cancer Discov."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41467-017-02674-y","article-title":"Genetic alterations driving metastatic colony formation are acquired outside of the primary tumour in melanoma","volume":"9","author":"Scheitler","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1056\/NEJMoa1406037","article-title":"Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma","volume":"371","author":"Long","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1158\/1078-0432.CCR-13-3122","article-title":"BRAF inhibitor resistance mechanisms in metastatic melanoma: Spectrum and clinical impact","volume":"20","author":"Rizos","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Gatzka, M.V. (2018). Targeted Tumor Therapy Remixed-An Update on the Use of Small-Molecule Drugs in Combination Therapies. Cancers, 10.","DOI":"10.3390\/cancers10060155"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","article-title":"KEYNOTE-006 investigators. Pembrolizumab versus Ipilimumab in Advanced Melanoma","volume":"372","author":"Robert","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Gajos-Michniewicz, A., and Czyz, M. (2019). Role of miRNAs in Melanoma Metastasis. Cancers, 11.","DOI":"10.3390\/cancers11030326"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e12457","DOI":"10.1111\/cpr.12457","article-title":"Long non-coding RNAs in melanoma","volume":"51","author":"Yu","year":"2018","journal-title":"Cell Prolif."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-981-10-5203-3_1","article-title":"History, Discovery, and Classification of lncRNAs","volume":"1008","author":"Jarroux","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejcb.2014.02.001","article-title":"The role of microRNAs in melanoma","volume":"93","author":"Luo","year":"2014","journal-title":"Eur. J. Cell Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nature07348","article-title":"Stepwise chromatin remodelling by a cascade of transcription initiation of non-coding RNAs","volume":"456","author":"Hirota","year":"2008","journal-title":"Nature"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1261\/rna.037598.112","article-title":"Noncoding RNA and Polycomb recruitment","volume":"19","author":"Brockdorff","year":"2013","journal-title":"RNA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature11993","article-title":"Natural RNA circles function as efficient microRNA sponges","volume":"495","author":"Hansen","year":"2013","journal-title":"Nature"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1093\/carcin\/bgs205","article-title":"MicroRNA and cutaneous melanoma: From discovery to prognosis and therapy","volume":"33","author":"Segura","year":"2012","journal-title":"Carcinogenesis"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1586\/1744666X.2016.1100965","article-title":"miRNAs in melanoma: A defined role in tumor progression and metastasis","volume":"12","author":"Mannavola","year":"2016","journal-title":"Exp. Rev. Clin. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Varrone, F., and Caputo, E. (2020). The miRNAs Role in Melanoma and in Its Resistance to Therapy. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21030878"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature03664","article-title":"Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma","volume":"436","author":"Garraway","year":"2005","journal-title":"Nature"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1101\/gad.406406","article-title":"Mitf regulation of Dia1 controls melanoma proliferation and invasiveness","volume":"20","author":"Carreira","year":"2006","journal-title":"Genes Dev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/j.1755-148X.2011.00931.x","article-title":"The three M\u2019s: Melanoma, microphthalmia-associated transcription factor and microRNA","volume":"24","author":"Bell","year":"2011","journal-title":"Pigment. Cell Melanoma Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1158\/0008-5472.CAN-07-2912","article-title":"MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines","volume":"68","author":"Bemis","year":"2008","journal-title":"Cancer Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1073\/pnas.0808263106","article-title":"Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor","volume":"106","author":"Segura","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1755-148X.2011.00849.x","article-title":"Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor","volume":"24","author":"Boyle","year":"2011","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40659-020-00278-3","article-title":"MicroRNA-107 is a novel tumor suppressor targeting POU3F2 in melanoma","volume":"53","author":"Zhao","year":"2020","journal-title":"Biol. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/jid.2012.357","article-title":"MiR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes","volume":"133","author":"Luo","year":"2013","journal-title":"J. Investig. Derm."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1038\/jid.2008.452","article-title":"MiRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma","volume":"129","author":"Mueller","year":"2009","journal-title":"J. Investig. Derm."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/jid.2013.340","article-title":"Transcription factor\/microRNA axis blocks melanoma invasion program by miR-211 targeting NUAK1","volume":"134","author":"Bell","year":"2014","journal-title":"J. Investig. Derm."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Mazar, J., DeYoung, K., Khaitan, D., Meister, E., Almodovar, A., Goydos, J., Ray, A., and Perera, R.J. (2010). The regulation of miRNA-211 expression and its role in melanoma cell invasiveness. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0013779"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ccr.2010.10.029","article-title":"Oncogenic BRAF induces melanoma cell invasion by downregulating the cGMP-specific phosphodiesterase PDE5A","volume":"19","author":"Arozarena","year":"2011","journal-title":"Cancer Cell"},{"key":"ref_50","first-page":"407","article-title":"Role of microRNAs in remodeling the tumor microenvironment (Review)","volume":"56","author":"Pan","year":"2020","journal-title":"Int. J. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"6698","DOI":"10.1038\/onc.2008.282","article-title":"Integrin beta 3 expression is regulated by let-7a miRNA in malignant melanoma","volume":"27","author":"Bosserhoff","year":"2008","journal-title":"Oncogene"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.yexcr.2010.11.004","article-title":"Let-7b-mediated suppression of basigin expression and metastasis in mouse melanoma cells","volume":"317","author":"Fu","year":"2011","journal-title":"Exp. Cell Res."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Martin del Campo, S.E., Latchana, N., Levine, K.M., Grignol, V.P., Fairchild, E.T., Jaime-Ramirez, A.C., Dao, T.V., Karpa, V.I., Carson, M., and Ganju, A. (2015). MiR-21 enhances melanoma invasiveness via inhibition of tissue inhibitor of metalloproteinases 3 expression: In vivo effects of MiR-21 inhibitor. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0115919"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ccr.2011.05.027","article-title":"MiR30b\/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis","volume":"20","author":"Segura","year":"2011","journal-title":"Cancer Cell"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.15252\/embr.201439392","article-title":"E2F1 induces miR 224\/452 expression to drive EMT through TXNIP downregulation","volume":"15","author":"Knoll","year":"2014","journal-title":"EMBO Rep."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1128\/MCB.00079-16","article-title":"Suppression of MicroRNA 200 Family Expression by Oncogenic KRAS Activation Promotes Cell Survival and Epithelial-Mesenchymal Transition in KRAS-Driven Cancer","volume":"36","author":"Zhong","year":"2016","journal-title":"Mol. Cell. Biol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1038\/emboj.2011.102","article-title":"microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C","volume":"30","author":"Penna","year":"2011","journal-title":"EMBO J."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.jid.2016.02.803","article-title":"Regulation of Melanoma Progression through the TCF4\/miR-125b\/NEDD9 Cascade","volume":"136","author":"Rambow","year":"2016","journal-title":"J. Investig. Derm."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1158\/0008-5472.CAN-13-0920","article-title":"Beta-catenin inhibitor ICAT modulates the invasive motility of melanoma cells","volume":"74","author":"Domingues","year":"2014","journal-title":"Cancer Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.cell.2012.10.028","article-title":"Convergent multi-miRNA targeting of ApoE drives LRP1\/LRP8 dependent melanoma metastasis and angiogenesis","volume":"151","author":"Pencheva","year":"2012","journal-title":"Cell"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"10128","DOI":"10.1158\/0008-5472.CAN-08-2148","article-title":"MicroRNAs impair MET-mediated invasive growth","volume":"68","author":"Migliore","year":"2008","journal-title":"Cancer Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"20826","DOI":"10.18632\/oncotarget.24846","article-title":"Exosomes in melanoma: A role in tumor progression, metastasis and impaired immune system activity","volume":"9","author":"Tucci","year":"2018","journal-title":"Oncotarget"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"101975","DOI":"10.1016\/j.ctrv.2020.101975","article-title":"The role of exosomes in metastasis and progression of melanoma","volume":"85","author":"Gowda","year":"2020","journal-title":"Cancer Treat. Rev."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1158\/0008-5472.CAN-10-4455","article-title":"Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis","volume":"71","author":"Hood","year":"2011","journal-title":"Cancer Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.mehy.2016.02.018","article-title":"Melanoma exosomes enable tumor tolerance in lymph nodes","volume":"90","author":"Hood","year":"2016","journal-title":"Med. Hypotheses"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nrc.2017.6","article-title":"Pre-metastatic niches: Organ-specific homes for metastases","volume":"17","author":"Peinado","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1158\/0008-5472.CAN-16-2634","article-title":"Long Noncoding RNA and Cancer: A New Paradigm","volume":"77","author":"Bhan","year":"2017","journal-title":"Cancer Res."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Dinescu, S., Ignat, S., Lazar, A.D., Constantin, C., Neagu, M., and Costache, M. (2019). Epitranscriptomic Signatures in lncRNAs and Their Possible Roles in Cancer. Genes, 10.","DOI":"10.3390\/genes10010052"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"S758","DOI":"10.21037\/tcr.2016.10.93","article-title":"Role of the lncRNAs in malignant melanoma and their involvement in metastasis","volume":"5","author":"Dalay","year":"2016","journal-title":"Transl Cancer Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1158\/0008-5472.CAN-10-4460","article-title":"The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion","volume":"71","author":"Khaitan","year":"2011","journal-title":"Cancer Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"8959","DOI":"10.18632\/oncotarget.1863","article-title":"The functional characterization of long noncoding RNA SPRY4-IT1 in human melanoma cells","volume":"5","author":"Mazar","year":"2014","journal-title":"Oncotarget"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e1298","DOI":"10.1038\/cddis.2014.256","article-title":"EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition","volume":"5","author":"Sun","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"11350","DOI":"10.1038\/s41598-019-47363-6","article-title":"Whole transcriptome analysis reveals correlation of long noncoding RNA ZEB1-AS1 with invasive profile in melanoma","volume":"9","author":"Siena","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/j.celrep.2016.04.018","article-title":"The lncRNA SLNCR1 Mediates Melanoma Invasion through a Conserved SRA1-like Region","volume":"15","author":"Schmidt","year":"2016","journal-title":"Cell Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/bies.201300068","article-title":"The non-coding skin: Exploring the roles of long non-coding RNAs in epidermal homeostasis and disease","volume":"35","author":"Hombach","year":"2013","journal-title":"Bioessays"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1101\/gr.140061.112","article-title":"BRAFV600E remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration","volume":"22","author":"Flockhart","year":"2012","journal-title":"Genome Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.3892\/ijo.2014.2691","article-title":"Long non-coding RNAs drive metastatic progression in melanoma","volume":"45","author":"Akhbari","year":"2014","journal-title":"Int J. Oncol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1158\/0008-5472.CAN-06-2004","article-title":"Characterization of a germ-line deletion, including the entire INK4\/ARF locus, in a melanoma-neural system tumor family: Identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF","volume":"67","author":"Pasmant","year":"2007","journal-title":"Cancer Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"16490","DOI":"10.18632\/oncotarget.7503","article-title":"Mapping of deletion breakpoints at the CDKN2A locus in melanoma: Detection of MTAP-ANRIL fusion transcripts","volume":"7","author":"Xie","year":"2016","journal-title":"Oncotarget"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.canlet.2016.07.024","article-title":"ANRIL lncRNA triggers efficient therapeutic efficacy by reprogramming the aberrant INK4-hub in melanoma","volume":"381","author":"Xu","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nature17161","article-title":"Melanoma addiction to the long non-coding RNA SAMMSON","volume":"531","author":"Leucci","year":"2016","journal-title":"Nature"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"251098","DOI":"10.1155\/2013\/251098","article-title":"Long noncoding RNA HOTAIR is associated with motility, invasion, and metastatic potential of metastatic melanoma","volume":"2013","author":"Tang","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/CMR.0000000000000080","article-title":"Potential roles of abnormally expressed long noncoding RNA UCA1 and Malat-1 in metastasis of melanoma","volume":"24","author":"Tian","year":"2014","journal-title":"Melanoma Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s12032-016-0804-2","article-title":"LncRNA UCA1-miR-507-FOXM1 axis is involved in cell proliferation, invasion and G0\/G1 cell cycle arrest in melanoma","volume":"33","author":"Wei","year":"2016","journal-title":"Med. Oncol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/CMR.0000000000000560","article-title":"Long noncoding RNA X-inactive specific transcript promotes malignant melanoma progression and oxaliplatin resistance","volume":"29","author":"Pan","year":"2019","journal-title":"Melanoma Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.2147\/OTT.S98203","article-title":"LncRNA GAS5 is a critical regulator of metastasis phenotype of melanoma cells and inhibits tumor growth in vivo","volume":"9","author":"Chen","year":"2016","journal-title":"OncoTargets"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12935-019-1087-4","article-title":"LncRNA MEG3 promotes melanoma growth, metastasis and formation through modulating miR-21\/E-cadherin axis","volume":"20","author":"Wu","year":"2020","journal-title":"Cancer Cell Int."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3892\/ijo.2016.3377","article-title":"Lentiviral-mediated overexpression of long noncoding RNA GAS5 reduces invasion by mediating MMP2 expression and activity in human melanoma cells","volume":"48","author":"Chen","year":"2016","journal-title":"Int J. Oncol."},{"key":"ref_89","first-page":"1509","article-title":"Long non-coding RNA GAS5 inhibits tumorigenesis via miR-137 in melanoma","volume":"9","author":"Bian","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Lorusso, C., De Summa, S., Pinto, R., Danza, K., and Tommasi, S. (2020). miRNAs as Key Players in the Management of Cutaneous Melanoma. Cells, 9.","DOI":"10.3390\/cells9020415"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/ncb3399","article-title":"Melanoma miRNA trafficking controls tumour primary niche formation","volume":"18","author":"Dror","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1172\/JCI66715","article-title":"HIF1\u03b1 and HIF2\u03b1 independently activate SRC to promote melanoma metastases","volume":"123","author":"Hanna","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"King, H.W., Michael, M.Z., and Gleadle, J.M. (2012). Hypoxic enhancement of exosome release by breast cancer cells. BMC Cancer, 12.","DOI":"10.1186\/1471-2407-12-421"},{"key":"ref_94","first-page":"6779","article-title":"Analysis of the miRNA profiles of melanoma exosomes derived under normoxic and hypoxic culture conditions","volume":"37","author":"Wozniak","year":"2017","journal-title":"Anticancer Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.molcel.2010.09.022","article-title":"Hypoxia-inducible factors and the response to hypoxic stress","volume":"40","author":"Majmundar","year":"2010","journal-title":"Mol. Cell"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/pcmr.12255","article-title":"Distinct microRNA expression signatures are associated with melanoma subtypes and are regulated by HIF1A","volume":"27","author":"Hwang","year":"2014","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e1127","DOI":"10.1038\/cddis.2014.94","article-title":"BNIP3 supports melanoma cell migration and vasculogenic mimicry by orchestrating the actin cytoskeleton","volume":"5","author":"Maes","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1515\/hsz-2018-0208","article-title":"BNIP3 contributes to the glutamine-driven aggressive behavior of melanoma cells","volume":"400","author":"Maes","year":"2019","journal-title":"Biol. Chem."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1128\/MCB.00762-15","article-title":"MicroRNA 211 Functions as a Metabolic Switch in Human Melanoma Cells","volume":"36","author":"Mazar","year":"2016","journal-title":"Mol. Cell. Biol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrc2868","article-title":"Targeting the tumour vasculature: Insights from physiological angiogenesis","volume":"10","author":"Chung","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrc1093","article-title":"Tumorigenesis and the angiogenic switch","volume":"3","author":"Bergers","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1038\/emboj.2012.183","article-title":"Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway","volume":"31","author":"Zhuang","year":"2012","journal-title":"EMBO J."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccr.2008.12.004","article-title":"PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment","volume":"15","author":"Crawford","year":"2009","journal-title":"Cancer Cell"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1158\/0008-5472.CAN-08-2724","article-title":"Paracrine signaling by platelet-derived growth factor-CC promotes tumor growth by recruitment of cancer-associated fibroblasts","volume":"69","author":"Anderberg","year":"2009","journal-title":"Cancer Res."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Vallacchi, V., Camisaschi, C., Dugo, M., Vergani, E., Deho, P., Gualeni, A., Huber, V., Gloghini, A., Maurichi, A., and Santinami, M. (2016). MicroRNA Expression in Sentinel Nodes from Progressing Melanoma Patients Identifies Networks Associated with Dysfunctional Immune Response. Genes, 7.","DOI":"10.3390\/genes7120124"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1158\/0008-5472.CAN-12-1383","article-title":"Hypoxia-inducible miR-210 regulates the susceptibility of tumor cells to lysis by cytotoxic T cells","volume":"72","author":"Noman","year":"2012","journal-title":"Cancer Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1158\/0008-5472.CAN-14-2331","article-title":"Host miR155 promotes tumor growth through a myeloid-derived suppressor cell-dependent mechanism","volume":"75","author":"Chen","year":"2015","journal-title":"Cancer Res."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1158\/0008-5472.CAN-07-0520","article-title":"Tumor-released microvesicles as vehicles of immunosuppression","volume":"67","author":"Valenti","year":"2007","journal-title":"Cancer Res."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Ding, H., Yang, X., and Wei, Y. (2018). Fusion Proteins of NKG2D\/NKG2DL in Cancer Immunotherapy. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19010177"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1158\/0008-5472.CAN-11-1977","article-title":"Tumor suppressive microRNAs miR-34a\/c control cancer cell expression of ULBP2, a stress-induced ligand of the natural killer cell receptor NKG2D","volume":"72","author":"Heinemann","year":"2012","journal-title":"Cancer Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.1158\/1078-0432.CCR-09-0886","article-title":"Differential clinical significance of individual NKG2D ligands in melanoma: Soluble ULBP2 as an indicator of poor prognosis superior to S100B","volume":"15","author":"Paschen","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.aaf1328","article-title":"SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactions","volume":"352","author":"Pucci","year":"2016","journal-title":"Science"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/ijc.31774","article-title":"Exosomes Play Roles in Sequential Processes of Tumor Metastasis","volume":"144","author":"Li","year":"2019","journal-title":"Int J. Cancer"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1002\/jcp.25789","article-title":"HOTAIR role in melanoma progression and its identification in the blood of patients with advanced disease","volume":"232","author":"Cantile","year":"2017","journal-title":"J. Cell Physiol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"15670","DOI":"10.1038\/s41598-018-33722-2","article-title":"LncRNA HOTAIR regulates lipopolysaccharide-induced cytokine expression and inflammatory response in macrophages","volume":"8","author":"Obaid","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Botti, G., Scognamiglio, G., Aquino, G., Liguori, G., and Cantile, M. (2019). LncRNA HOTAIR in Tumor Microenvironment: What Role?. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20092279"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.18632\/oncotarget.6599","article-title":"Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b","volume":"7","author":"Vergani","year":"2016","journal-title":"Oncotarget"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/pcmr.12578","article-title":"MicroRNA-125a promotes resistance to BRAF inhibitors through suppression of the intrinsic apoptotic pathway","volume":"30","author":"Hanniford","year":"2017","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1158\/0008-5472.CAN-17-1318","article-title":"MiR-204-5p and miR-211-5p Contribute to BRAF Inhibitor Resistance in Melanoma","volume":"78","author":"Alonso","year":"2018","journal-title":"Cancer Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"248","DOI":"10.18632\/oncoscience.443","article-title":"Biological role of miR-204 and miR-211 in melanoma","volume":"5","author":"Vitiello","year":"2018","journal-title":"Oncoscience"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"17753","DOI":"10.18632\/oncotarget.3924","article-title":"miR-514a regulates the tumour suppressor NF1 and modulates BRAFi sensitivity in melanoma","volume":"6","author":"Stark","year":"2015","journal-title":"Oncotarget"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"53558","DOI":"10.18632\/oncotarget.10669","article-title":"miR-7 reverses the resistance to BRAFi in melanoma by targeting EGFR\/IGF-1R\/CRAF and inhibiting the MAPK and PI3K\/AKT signaling pathways","volume":"7","author":"Sun","year":"2016","journal-title":"Oncotarget"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Mishra, P.J., and Merlino, G. (2016). Integrated Genomics Identifies miR-32\/MCL-1 Pathway as a Critical Driver of Melanomagenesis: Implications for miR-Replacement and Combination Therapy. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0165102"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/pcmr.12379","article-title":"miR-200c\/Bmi1 axis and epithelial-mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment","volume":"28","author":"Liu","year":"2015","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"E5005","DOI":"10.1073\/pnas.1607753113","article-title":"miR-579-3p controls melanoma progression and resistance to target therapy","volume":"113","author":"Fattore","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"10902","DOI":"10.1038\/s41598-018-27643-3","article-title":"The lincRNA MIRAT binds to IQGAP1 and modulates the MAPK pathway in NRAS mutant melanoma","volume":"8","author":"Sanlorenzo","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature23451","article-title":"Genome-scale activation screen identifies a lncRNA locus regulating a gene neighbourhood","volume":"548","author":"Joung","year":"2017","journal-title":"Nature"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.semcancer.2019.11.006","article-title":"Noncoding RNAs as potential mediators of resistance to cancer immunotherapy","volume":"65","author":"Vishnubalaji","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.3389\/fonc.2019.01292","article-title":"The Role of Long Non-coding RNAs in Immunotherapy Resistance","volume":"9","author":"Zhou","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1172\/JCI98060","article-title":"Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma","volume":"128","author":"Huber","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"53735","DOI":"10.18632\/oncotarget.10731","article-title":"miR-28 modulates exhaustive differentiation of T cells through silencing programmed cell death-1 and regulating cytokine secretion","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"15894","DOI":"10.18632\/oncotarget.15213","article-title":"PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p","volume":"8","author":"Audrito","year":"2017","journal-title":"Oncotarget"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1158\/2326-6066.CIR-18-0443","article-title":"The pseudogene Olfr29-ps1 promotes the suppressive function and differentiation of monocytic MDSCs","volume":"7","author":"Shang","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.4049\/jimmunol.1701721","article-title":"Lnc-chop promotes immunosuppressive function of myeloid-derived suppressor cells in tumor and inflammatory environments","volume":"200","author":"Gao","year":"2018","journal-title":"J. Immunol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"59704","DOI":"10.18632\/oncotarget.10923","article-title":"IRES-dependent translation of the long non coding RNA meloe in melanoma cells produces the most immunogenic MELOE antigens","volume":"7","author":"Charpentier","year":"2016","journal-title":"Oncotarget"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1084\/jem.20081356","article-title":"MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency","volume":"205","author":"Godet","year":"2008","journal-title":"J. Exp. Med."},{"key":"ref_137","first-page":"1758835918794630","article-title":"Liquid biopsy of cancer: A multimodal diagnostic tool in clinical oncology","volume":"10","author":"Palmirotta","year":"2018","journal-title":"Adv. Med. Oncol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrc3066","article-title":"Cell-free nucleic acids as biomarkers in cancer patients","volume":"11","author":"Schwarzenbach","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.semcancer.2019.01.003","article-title":"The circulating transcriptome as a source of cancer liquid biopsy biomarkers","volume":"58","author":"Sole","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Leidinger, P., Keller, A., Borries, A., Reichrath, J., Rass, K., Jager, S.V., Lenhof, H.-P., and Meeseet, E. (2010). High-throughput miRNA profiling of human melanoma blood samples. BMC Cancer, 10.","DOI":"10.1186\/1471-2407-10-262"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Mumford, S.L., Towler, B.P., Pashler, A.L., Gilleard, O., Martin, Y., and Newbury, S.F. (2018). Circulating MicroRNA Biomarkers in Melanoma: Tools and Challenges in Personalised Medicine. Biomolecules, 8.","DOI":"10.3390\/biom8020021"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.3390\/jcm4121957","article-title":"Detection of Exosomal miRNAs in the Plasma of Melanoma Patients","volume":"4","author":"Pfeffer","year":"2015","journal-title":"J. Clin. Med."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Mannavola, F., D\u2019Oronzo, S., Cives, M., Stucci, L.S., Ranieri, G., Silvestris, F., and Tucci, M. (2020). Extracellular Vesicles and Epigenetic Modifications Are Hallmarks of Melanoma Progression. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21010052"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2340\/00015555-2156","article-title":"Identification of a Circulating MicroRNA Profile as a Biomarker of Metastatic Cutaneous Melanoma","volume":"96","author":"Meyer","year":"2016","journal-title":"Acta Derm. Venereol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/bjc.2017.477","article-title":"Development and validation of a plasma-based melanoma biomarker suitable for clinical use","volume":"118","author":"Lincoln","year":"2018","journal-title":"Br. J. Cancer"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.12659\/MSM.891327","article-title":"Circulating miR-221 expression level and prognosis of cutaneous malignant melanoma","volume":"20","author":"Li","year":"2014","journal-title":"Med. Sci Monit."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/cncr.28981","article-title":"Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients","volume":"121","author":"Fleming","year":"2015","journal-title":"Cancer"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ebiom.2015.05.011","article-title":"The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis","volume":"2","author":"Stark","year":"2015","journal-title":"EBioMedicine"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/2211-5463.12030","article-title":"Clinical significance of long noncoding RNA SPRY4-IT1 in melanoma patients","volume":"6","author":"Liu","year":"2016","journal-title":"FEBS Open Bio"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrg3074","article-title":"Non-coding RNAs in human disease","volume":"12","author":"Esteller","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"43470","DOI":"10.18632\/oncotarget.16478","article-title":"Long non-coding RNAs in cutaneous melanoma: Clinical perspectives","volume":"8","author":"Hulstaert","year":"2017","journal-title":"Oncotarget"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-907X-3-1","article-title":"Inhibition of microRNA function by antimiR oligonucleotides","volume":"3","author":"Stenvang","year":"2012","journal-title":"Silence"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1002\/jcp.26514","article-title":"Treating cancer with microRNA replacement therapy: A literature review","volume":"233","author":"Hosseinahli","year":"2018","journal-title":"J. Cell Physiol."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Fattore, L., Campani, V., Ruggiero, C.F., Salvati, V., Liguoro, D., Scotti, L., Botti, G., Ascierto, P.A., Mancini, R., and De Rosa, G. (2020). In Vitro Biophysical and Biological Characterization of Lipid Nanoparticles Co-Encapsulating Oncosuppressors miR-199b-5p and miR-204-5p as Potentiators of Target Therapy in Metastatic Melanoma. Int. J. Molec. Sci., 21.","DOI":"10.3390\/ijms21061930"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.abb.2014.07.022","article-title":"The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma","volume":"563","author":"Aftab","year":"2014","journal-title":"Arch. Biochem. Biophys."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/11\/3378\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:33:38Z","timestamp":1760178818000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/11\/3378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,15]]},"references-count":155,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11]]}},"alternative-id":["cancers12113378"],"URL":"https:\/\/doi.org\/10.3390\/cancers12113378","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,15]]}}}